Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunogenicity Studies of Plant-Produced SARS-CoV-2 Receptor Binding Domain-Based Subunit Vaccine Candidate with Different Adjuvant Formulations
Konlavat Siriwattananon, Suwimon Manopwisedjaroen, Balamurugan Shanmugaraj, et al.
Vaccines (2021) Vol. 9, Iss. 7, pp. 744-744
Open Access | Times Cited: 24

Showing 24 citing articles:

Plant-Derived Human Vaccines: Recent Developments
Jennifer Stander, Sandiswa Mbewana, Ann E. Meyers
BioDrugs (2022) Vol. 36, Iss. 5, pp. 573-589
Open Access | Times Cited: 36
Preclinical evaluation of a plant-derived SARS-CoV-2 subunit vaccine: Protective efficacy, immunogenicity, safety, and toxicity
Balamurugan Shanmugaraj, Narach Khorattanakulchai, Chalisa Panapitakkul, et al.
Vaccine (2022) Vol. 40, Iss. 32, pp. 4440-4452
Open Access | Times Cited: 31
Long-term persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein-specific and neutralizing antibodies in recovered COVID-19 patients
Jira Chansaenroj, Ritthideach Yorsaeng, Jiratchaya Puenpa, et al.
PLoS ONE (2022) Vol. 17, Iss. 4, pp. e0267102-e0267102
Open Access | Times Cited: 29
Advances in SARS-CoV-2 receptor-binding domain-based COVID-19 vaccines
Xiao‐Qing Guan, Yang Yang, Lanying Du
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 422-439
Open Access | Times Cited: 16
A plant-produced SARS-CoV-2 spike protein elicits heterologous immunity in hamsters
Emmanuel Margolin, Georgia Schäfer, Joel D. Allen, et al.
Frontiers in Plant Science (2023) Vol. 14
Open Access | Times Cited: 15
Plant Viruses as Adjuvants for Next-Generation Vaccines and Immunotherapy
Nikolai A. Nikitin, Yuri Vasiliev, Angelina Kovalenko, et al.
Vaccines (2023) Vol. 11, Iss. 8, pp. 1372-1372
Open Access | Times Cited: 12
A Novel Bacterial Protease Inhibitor Adjuvant in RBD-Based COVID-19 Vaccine Formulations Containing Alum Increases Neutralizing Antibodies, Specific Germinal Center B Cells and Confers Protection Against SARS-CoV-2 Infection in Mice
Lorena M. Coria, Lucas M. Saposnik, Celeste Pueblas Castro, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17
Receptor binding domain proteins of SARS‐CoV‐2 variants produced in Nicotiana benthamiana elicit neutralizing antibodies against variants of concern
Narach Khorattanakulchai, Suwimon Manopwisedjaroen, Kaewta Rattanapisit, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 9, pp. 4265-4276
Open Access | Times Cited: 16
Potential for Developing Plant-Derived Candidate Vaccines and Biologics against Emerging Coronavirus Infections
Balamurugan Shanmugaraj, Konlavat Siriwattananon, Ashwini Malla, et al.
Pathogens (2021) Vol. 10, Iss. 8, pp. 1051-1051
Open Access | Times Cited: 21
Silk fibroin-based hydrogel as injectable carrier for prolonged immunization of plant-based COVID-19 subunit vaccine
Nopparuj Soomherun, Ruttanaporn Kriangsaksri, Wanlapa Tanticharakunsiri, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 95, pp. 105574-105574
Closed Access | Times Cited: 2
Preclinical assessment of a recombinant RBD-Fc fusion protein as SARS-CoV-2 candidate vaccine
Navid Dashti, Forough Golsaz‐Shirazi, Haleh Soltanghoraee, et al.
European Journal of Microbiology and Immunology (2024) Vol. 14, Iss. 3, pp. 228-242
Open Access | Times Cited: 2
Plant Molecular Pharming and Plant-Derived Compounds towards Generation of Vaccines and Therapeutics against Coronaviruses
Srividhya Venkataraman
Vaccines (2022) Vol. 10, Iss. 11, pp. 1805-1805
Open Access | Times Cited: 9
Plant-based vaccines for emerging infectious diseases
Lalitkumar K. Vora, Vivek P. Chavda, Nidhi Raval, et al.
Elsevier eBooks (2024), pp. 115-129
Closed Access | Times Cited: 1
Aluminum hydroxide and immunostimulatory glycolipid adjuvant combination for enhanced COVID-19 subunit vaccine immunogenicity
Guo-Qing Zou, Ke Li, Cheng Yan, et al.
Vaccine (2024) Vol. 42, Iss. 21, pp. 126145-126145
Closed Access | Times Cited: 1
Using Dual Toll-like Receptor Agonism to Drive Th1-Biased Response in a Squalene- and α-Tocopherol-Containing Emulsion for a More Effective SARS-CoV-2 Vaccine
Kristopher K. Short, Stephanie K. Lathrop, Clara J. Davison, et al.
Pharmaceutics (2022) Vol. 14, Iss. 7, pp. 1455-1455
Open Access | Times Cited: 8
Intradermal Immunization of SARS-CoV-2 Original Strain Trimeric Spike Protein Associated to CpG and AddaS03 Adjuvants, but Not MPL, Provide Strong Humoral and Cellular Response in Mice
Luan Firmino-Cruz, Júlio Souza dos-Santos, Alessandra Marcia da Fonseca-Martins, et al.
Vaccines (2022) Vol. 10, Iss. 8, pp. 1305-1305
Open Access | Times Cited: 6
Receptor‐binding domain‐based SARS‐CoV‐2 vaccine adjuvanted with cyclic di‐adenosine monophosphate enhances humoral and cellular immunity in mice
María José Germanó, Constanza Giai, Diego Esteban Cargnelutti, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 2
Closed Access | Times Cited: 3
Enhancing COVID-19 Vaccine Efficacy: Dual Adjuvant Strategies with TLR7/8 Agonists and Glycolipids
Ke Li, Xing Hu, Xinyi Tu, et al.
Journal of Medicinal Chemistry (2024)
Closed Access
Antigenicity and immunogenicity of SARS-CoV-2 surface glycoprotein fragment in CHO cells
Sahar Karimi, Shahram Nazarian, Fattah Sotoodehnejadnematalahi, et al.
Iranian Journal of Microbiology (2023)
Open Access | Times Cited: 1
Development of new binary expression systems for plant synthetic biology
Alexander C. Pfotenhauer, Dirk Reuter, Mikayla M. Clark, et al.
Plant Cell Reports (2023) Vol. 43, Iss. 1
Closed Access | Times Cited: 1
A novel bacterial protease inhibitor adjuvant in RBD-based COVID-19 vaccine formulations increases neutralizing antibodies, specific germinal center B cells and confers protection against SARS-CoV-2 infection
Lorena M. Coria, Lucas M. Saposnik, Celeste Pueblas Castro, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 2
Immunodominance of epitopes and protection efficacy of RBD antigen are differentially altered by different adjuvants and immune pathways
Sisi Li, Lianli Duan, Xiaoli Zhang, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1
The Race to Manufacture COVID-19 Vaccines: Emerging Vaccine Technologies

(2023)
Open Access
Immunodominance of epitopes and protection efficacy of RBD antigen are differentially altered by different adjuvants and immune routes
Sisi Li, Lianli Duan, Xiaoli Zhang, et al.
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top